Thromboembolic complications in fontan patients: Population-based prevalence and exploration of the etiology

Pediatric Cardiology

Volumn 34, Issue 2, 2013, Pages 262-272

  Idorn, L ^a   Jensen, A S ^a   Juul, K ^a   Reimers, J I ^a   Johansson, P I ^a   Sorensen K E ^b   Ostrowski, S R ^a   Sondergaard L ^a  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Coagulation; Fontan procedure; Hematology; Prevalence; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BIOLOGICAL MARKER; CD40 LIGAND; DNA FRAGMENT; FIBRINOGEN; HEPARIN; HISTONE; HISTONE COMPLEXED DNA FRAGMENT; PROTEIN C; SYNDECAN 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOT; BLOOD CLOTTING PARAMETERS; CONTROLLED STUDY; DENMARK; DNA HISTONE INTERACTION; ENDOTHELIUM LESION; FEMALE; FIBRINOLYSIS; FOLLOW UP; FONTAN PROCEDURE; GLYCOCALYX; GROUPS BY AGE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSTOPERATIVE THROMBOSIS; PREVALENCE; PROTEIN DEGRADATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL RISK; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; THROMBOEMBOLISM;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD COAGULATION; CROSS-SECTIONAL STUDIES; DENMARK; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; PLATELET AGGREGATION; POPULATION SURVEILLANCE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBELASTOGRAPHY; THROMBOEMBOLISM; TIME FACTORS;

EID: 84879497805     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0431-4     Document Type: Article

References (34)

1. Anttonen A, Leppa S, Ruotsalainen T, Alfthan H, Mattson K, Joensuu H (2003) Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 41:171-177
2. Balling G, Vogt M, Kaemmerer H, Eicken A, Meisner H, Hess J (2000) Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 119:745-752
3. Binotto MA, Maeda NY, Lopes AA (2008) Altered endothelial function following the Fontan procedure. Cardiol Young 18:70-74
4. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R et al (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919-933
5. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP et al (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561
6. Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL (2001) Thrombus formation after the Fontan operation. Ann Thorac Surg 71:1990-1994
7. Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, Hillege HL, Bom VJ, van der Meer J (1990) Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 336:1087-1090
8. Gerdes VE, Kremer Hovinga JA, Ten CH, Brandjes DP, Buller HR (2004) Soluble thrombomodulin in patients with established atherosclerosis. J Thromb Haemost 2:200-201
9. Guide to functional fibrinogen (2007) Haemoscope, Niles, IL, p 15. http://www.haemoscope.com. Accessed 1 Jan 2010
10. Inai K, Saita Y, Takeda S, Nakazawa M, Kimura H (2004) Skeletal muscle hemodynamics and endothelial function in patients after Fontan operation. Am J Cardiol 93:792-797
11. Jacobs ML, Pourmoghadam KK (2007) Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol 28:457-464
12. Jahangiri M, Shore D, Kakkar V, Lincoln C, Shinebourne E (1997) Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 113:989-992
13. Johansson PI, Bochsen L, Andersen S, Viuff D (2008) Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion 48:2377-2383
14. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR (2011) A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 254:194-200
15. Kajimoto H, Nakazawa M, Murasaki K, Hagiwara N, Nakanishi T (2009) Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients. Circ J 73:1705-1710
16. Kaulitz R, Luhmer I, Bergmann F, Rodeck B, Hausdorf G (1997) Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart 78:154-159
17. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE et al (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85-92
18. Mahle WT, Todd K, Fyfe DA (2003) Endothelial function following the Fontan operation. Am J Cardiol 91:1286-1288
19. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E (2005) Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 100:1576-1583
20. Monagle P, Cochrane A, McCrindle B, Benson L, Williams W, Andrew M (1998) Thromboembolic complications after Fontan procedures - The role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 115:493-498
21. Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B et al (2011) A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 58:645-651
22. Monroe DM, Hoffman M (2006) What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 26:41-48
23. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J et al (2004) Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 109:1343-1348
24. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES (2005) The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 16:507-511
25. Raffini L, Schwed A, Zheng XL, Tanzer M, Nicolson S, Gaynor JW et al (2009) Thromboelastography of patients after Fontan compared with healthy children. Pediatr Cardiol 30:771-776
26. Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kromann O, Pedersen J et al (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85:61-65
27. Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M et al (2004) Endothelial glycocalyx as an additional barrier determining extravasation of 6 % hydroxyethyl starch or 5 % albumin solutions in the coronary vascular bed. Anesthesiology 100:1211-1223
28. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M et al (2007) Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116:1896-1906
29. Robbers-Visser D, Miedema M, Nijveld A, Boersma E, Bogers AJ, Haas F et al (2010) Results of staged total cavopulmonary connection for functionally univentricular hearts; comparison of intra-atrial lateral tunnel and extracardiac conduit. Eur J Cardiothorac Surg 37:934-941
30. Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE (1995) Thromboembolic complications after Fontan operations. Circulation 92:287-293
31. Shirai LK, Rosenthal DN, Reitz BA, Robbins RC, Dubin AM (1998) Arrhythmias and thromboembolic complications after the extracardiac Fontan operation. J Thorac Cardiovasc Surg 115:499-505
32. van den Bosch AE, Roos-Hesselink JW, Van DR, Bogers AJ, Simoons ML, Meijboom FJ (2004) Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol 93:1141-1145
33. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ (1999) Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82:40-46
34. Varma C, Warr MR, Hendler AL, Paul NS, Webb GD, Therrien J (2003) Prevalence of "silent" pulmonary emboli in adults after the Fontan operation. J Am Coll Cardiol 41:2252-2258